Rushford Center Inc MISA OP

Rushford Center Inc MISA OP is a Joint Commission-accredited addiction treatment center located at 1250 Silver St in Meriden, Connecticut, in Middlesex County. The facility provides a full continuum of care — from medically supervised detox through longer-term residential programming — making it one of the more comprehensive treatment options in the region for individuals managing acute withdrawal and ongoing recovery needs.

For those requiring immediate withdrawal management, Rushford Center offers medical detox as the entry point into care. Beyond detox, the facility provides residential inpatient treatment, extended residential programming, outpatient services, and medication-assisted treatment (MAT). This range of levels of care means that patients can transition from medically supervised detox into structured inpatient or outpatient programs without leaving the Rushford system.

Treatment at Rushford Center addresses alcohol addiction, opioid addiction, and co-occurring mental health conditions — a combination known in clinical settings as MISA, or Mental Illness and Substance Abuse, which is reflected in the program’s formal name. Therapeutic methods include group therapy, relapse prevention, and esketamine treatment, the latter being a notably specialized clinical offering not commonly available at standard detox and addiction programs. Services are provided in both English and Spanish.

Rushford Center serves both adults and teens, which distinguishes it from many detox-focused facilities that limit intake to adults only. Joint Commission accreditation signals that the center meets nationally recognized standards for clinical care. For families or individuals weighing same-day or urgent decisions about inpatient detox or withdrawal management in Connecticut, Rushford Center’s continuum — from medical detox through extended residential — offers a structured path without requiring transfer to a separate facility.

Rushford Center Inc MISA OP provides medical detox as the clinical foundation of its addiction treatment continuum. For individuals experiencing withdrawal from alcohol or opioids, medically supervised detox offers structured monitoring and intervention during the most physically acute phase of stopping substance use. This level of care is available on-site in Meriden, CT, allowing patients to begin stabilization without delays caused by facility transfers.

Following detox, patients can step directly into residential inpatient or extended residential programming within the same system. This continuity matters for individuals whose withdrawal management needs are closely tied to underlying addiction severity or co-occurring mental health conditions — both of which Rushford is equipped to address under its MISA-model programming.

Rushford Center offers five distinct levels of care: medical detox, residential inpatient, extended residential, outpatient, and medication-assisted treatment. This range allows clinicians to match placement to clinical need rather than forcing patients into a one-size program. Medication-assisted treatment (MAT) is integrated into the continuum, supporting opioid addiction treatment with FDA-approved pharmacological protocols alongside behavioral interventions.

The facility's outpatient program provides continued support after residential or detox-level care, enabling patients to maintain treatment engagement while transitioning back to daily life. For those requiring longer stabilization, the extended residential option extends time in a structured setting beyond standard inpatient timelines.

Rushford Center's MISA designation — Mental Illness and Substance Abuse — reflects its clinical focus on treating addiction and mental health conditions simultaneously rather than in sequence. Alcohol addiction, opioid addiction, and mental health conditions are all listed among the conditions treated at this facility. This integrated model is particularly relevant for patients who have cycled through detox programs without sustained results due to untreated psychiatric conditions.

Therapeutic methods at Rushford include group therapy, relapse prevention, and esketamine treatment. Esketamine is an FDA-approved nasal spray used in treatment-resistant depression — its availability here signals a clinical depth uncommon at most detox or residential programs, and reflects the facility's dual focus on mental health alongside substance use disorders.

Rushford Center treats both adults and teens, making it one of the Connecticut facilities where adolescents can access the same full continuum — including medical detox, residential inpatient, and MAT — available to adult patients. Services are provided in English and Spanish, extending access to Spanish-speaking individuals and families navigating addiction treatment decisions.

The facility is Joint Commission accredited, a standard that reflects adherence to established clinical benchmarks for patient care, safety, and program quality. For individuals or families in Middlesex County and the surrounding Connecticut region who are making urgent decisions about inpatient detox or withdrawal management, Rushford Center can be reached at (860) 346-0300.